<DOC>
	<DOCNO>NCT00686920</DOCNO>
	<brief_summary>This study look safety drug use patient hepatic encephalopathy past .</brief_summary>
	<brief_title>Safety Study Patients With History Hepatic Encephalopathy</brief_title>
	<detailed_description />
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<criteria>Must sign Informed Consent Form In remission past hepatic encephalopathy ( HE ) . Appropriate birth control measure More equal 18 year age . Must potential benefit treatment . Recent HE episodes Capable willing comply study procedure . Subject support network . Significant medical condition Investigator decision include . Allergies study drug similar drug . Laboratory abnormality . Recent participation another clinical trial Problems experience previous HE trial . Pregnant risk pregnancy . Recent alcohol consumption Active latent bacterial viral Infections Bowel issue Recent Active Cancer On prohibit medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>